Key Highlights
- Bitnomial brings the first U.S.-regulated Injective (INJ) futures.
- The move allows regulated trading of futures to both institutional and individual users.
- It marks another addition to the Bitnomial crypto derivatives platform, with other products such as Tezos futures.
Bitnomial Exchange, a derivatives exchange company, today rolled out the first U.S.-regulated futures contracts for Injective (INJ).
According to the official announcement, the launch offers institutional and retail participants a regulated venue for INJ price exposure, hedging, and portfolio construction. INJ futures are crypto-settled with monthly expirations.
Users have the flexibility to margin with cryptocurrency or USD through the Bitnomial Clearinghouse, LLC. These futures contracts are available on Bitnomial Exchange through its Futures Commission Merchants (FCMs).
Injective is a Layer 1 blockchain focused on finance-related applications. Some characteristics of Injective include the fully on-chain order book, cross-chain executions across multiple blockchains, including IBC, Ethereum, and Solana networks, sub-second finality, and near-zero gas fees.
Institutional interest in Injective
Michael Dunn, President of Bitnomial Exchange, LLC, commented on the development, stating, “Injective has built one of the more technically ambitious Layer 1 blockchains in the market.” He added, “Listing INJ futures gives traders a regulated instrument to express a view on that thesis and adds another building block toward a potential spot ETF under the SEC’s generic listing standards.”
Meanwhile, Eric Chen, co-founder of Injective, highlighted the growing digital asset space, stating, “Regulated U.S. derivatives markets represent a critical milestone for any digital asset seeking broad institutional participation. The launch of INJ futures on Bitnomial’s CFTC-regulated exchange validates the demand for institutional-grade access to Injective and opens the door for a wider range of market participants to engage with the network.”
The protocol has listed validators, including Google Cloud and Binance. Adding more to this, Canary Capital has filed with the SEC for a potential staked INJ ETF, further highlighting growing institutional interest in the ecosystem.
Recent rollout and upcoming plans
In February 2026, Bitnomial, Inc., introduced the first Tezos (XTZ) US dollar futures contract on its platform. The introduction was an expanded regulated access to Tezos futures in the U.S. for the first time in a regulated environment, using cryptocurrency or USD margin.
INJ futures has joined Bitnomial’s crypto complex, which adds to Bitnomial’s crypto derivatives lineup. Contracts on the platform settle in crypto and back margining with digital assets, a structure Bitnomial says may improve capital efficiency compared with cash-only venues.
Bitnomial has further plans to introduce INJ perpetual futures and options. Retail access will follow in the near future via Botanical, the retail trading platform of Bitnomial.
Broader outlook
Through its crypto-settled products with flexible margins, Bitnomial’s model differs from cash-settled markets. The listing of INJ allows regulated access to new Layer 1 projects designed for decentralized finance.
As the regulatory environment within the United States becomes more defined concerning digital assets, the introduction of INJ futures could broaden regulated derivatives access to Layer 1 tokens, all through a CFTC-regulated exchange framework.
Also Read: Etherscan Unveils Beta Token Holders Overview for ERC-20 Tokens
